Effects of trichostatin A on neuronal mu-opioid receptor gene expression

Brain Research

Volumn 1246, Issue , 2008, Pages 1-10

  Lin, Ying Chih ^a   Flock, Kelly E ^a   Cook, Ryan J ^a   Hunkele, Amanda J ^a   Loh, Horace H ^b   Ko, Jane L ^a  

^a SETON HALL UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

mRNA degradation; Neuronal MOR gene expression; Proximal promoter; Sp1 Sp3 and PCBP factors; Transcriptional activation; Trichostatin A

Indexed keywords

BINDING PROTEIN; DOUBLE STRANDED DNA; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; MESSENGER RNA; MU OPIATE RECEPTOR; POLYC BINDING PROTEIN1; SINGLE STRANDED DNA; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN STABILITY; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; STEADY STATE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; ENZYME INHIBITORS; GENE EXPRESSION; GENES, REPORTER; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; MICROSCOPY, CONFOCAL; NEURONS; PROMOTER REGIONS, GENETIC; RECEPTORS, OPIOID, MU; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR;

EID: 57249103322     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.09.083     Document Type: Article

References (44)

1. Bannister A.J., and Miska E.A. Regulation of gene expression by transcription factor acetylation. Cell. Mol. Life Sci. 57 (2000) 1184-1192
2. Bare L.A., Mansson E., and Yang D. Expression of two variants of the human mu-opioid receptor mRNA in SK-N-SH cells and human brain. FEBS 354 (1994) 213-216
3. Berry A.M., Flock K.E., Loh H.H., and Ko J.L. Molecular basis underlying the cellular localization of poly C binding protein 1 in neuronal cells. Biochem. Biophys. Res. Commun. 349 (2006) 1378-1386
4. Berube N., Smeenk C., and Picketts D. Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Hum. Mol. Genet. 9 (2000) 539-547
5. Chen Y., Mestek A., Liu J., Hurley J.A., and Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol. Pharmacol. 44 (1993) 8-12
6. Choe C., Im H.J., Ko J.L., and Loh H.H. Mouse mu opioid receptor gene expression: a 34-bp cis-acting element inhibits transcription of the mu opioid receptor gene from the distal promoter. J. Biol. Chem. 273 (1998) 34926-34932
7. Cobb B., Morales-Alcelay S., Kleiger G., Brown K., Fisher A., and Smale S. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev. 14 (2000) 2146-2160
8. Conn K.J., Rich C.B., Jenson D.E., Fontanilla M.R., Bashir M.M., Rosenbloom J., and Foster J.A. Insulin-like growth factor-I regulates transcription of the elastin gene through a putative retinoblastoma control element. A role for Sp3 acting as a repressor of elastin gene transcription. J. Biol. Chem. 271 (1996) 28853-28860
9. Ghosh A.K., Mori Y., Dowling E., and Varga J. Trichostatin A blocks TGF-beta-induced collagen gene expression in skin fibroblasts: involvement of Sp1. Biochem. Biophys. Res. Commun. 354 (2007) 420-426
10. Glaser K.B., Staver M.J., Waring J.F., Stender J., Ulrich R.G., and Davidsen S.K. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol. Cancer Ther. 2 (2003) 151-163
11. Gu W., and Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90 (1997) 595-606
12. Hilton T.L., Li Y., Dunphy E.L., and Wang E.H. TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter. Mol. Cell. Biol. 25 (2005) 4321-4332
13. Januchowski R., Dabrowski M., Ofori H., and Jagodzinski P.P. Trichostatin A down-regulate DNA methyltransferase 1 in Jurkat T cells. Cancer Lett. 246 (2007) 313-317
14. Johnson D.R., Levant S., and Bale A.E. Direct molecular analysis of archival tumor tissue for loss of heterozygosity. BioTechniques 19 (1995) 192-195
15. Kieffer B.L., and Evan C.L. Opioid tolerance-in search of the holy grail. Cell 108 (2002) 587-590
16. Kieffer B.L., and Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66 (2002) 285-306
17. Kim S.S., Pandey K.K., Choi H.S., Law P.Y., Wei L.N., and Loh H.H. Poly C binding protein family is a transcription factor in mu-opioid receptor gene expression. Mol. Pharm. 68 (2005) 729-736
18. Ko J.L., and Loh H.H. Single-stranded DNA-binding complex involved in transcriptional regulation of mouse mu-opioid receptor gene. J. Biol. Chem. 276 (2001) 788-795
19. Ko J.L., and Loh H.H. Poly C binding protein, a single-stranded DNA binding protein, regulates mouse mu-opioid receptor gene expression. J. Neurochem. 93 (2005) 749-761
20. Ko J.L., Minnerath S.R., and Loh H.H. Dual promoters of mouse mu-opioid receptor gene. Biochem. Biophys. Res. Commun. 234 (1997) 351-357
21. Ko J.L., Liu H.C., Minnerath S.R., and Loh H.H. Transcriptional regulation of mouse mu-opioid receptor gene. J. Biol. Chem. 273 (1998) 27678-27685
22. Ko J.L., Chen H.C., and Loh H.H. Differential promoter usage of mouse mu-opioid receptor gene during development. Mol. Brain Res. 104 (2002) 184-193
23. Ko J.L., Liu H.C., and Loh H.H. Role of an AP-2-like element in transcriptional regulation of mouse mu-opioid receptor gene. Mol. Brain Res. 112 (2003) 153-162
24. Koch T., Schulz S., Pfeiffer M., Klutzny M., Schroder H., Kahl E., and Hollt V. Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273 (1998) 13652-13657
25. Legube G., and Trouche D. Regulating histone acetyltransferases and deacetylases. EMBO Rep. 4 (2003) 944-947
26. Leonhardt H., Rahn H., Weinzierl P., Sporbert A., Cremer T., Zink D., and Cardoso C. Dynamics of DNA replication factories in living cells. J. Cell Biol. 149 (2000) 271-279
27. Liang Y., Mestek A., Yu L., and Carr L.G. Cloning and characterization of the promoter region of the mouse mu opioid receptor gene. Brain Res. 679 (1995) 82-88
28. Malik A.K., Flock K.E., Godavarithi C.L., Loh H.H., and Ko J.L. Molecular basis underlying the poly C binding protein 1 as a regulator of the proximal promoter of mouse mu-opioid receptor gene. Brain Res. 1112 (2006) 33-45
29. Mansour A., Fox C.A., Akil H., and Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18 (1995) 22-29
30. Min B.H., Augustin L.B., Felsheim R.F., Fuchs J.A., and Loh H.H. Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene. Proc. Natl. Acad. Sci. U. S. A 91 (1994) 9081-9085
31. Mitsiades C.S., Mitsiades N.S., McMullan C.J., Poulaki V., Shringarpure R., Hideshima T., Akiyama M., Chauhan D., Munshi N., Gu X., Bailey C., Joseph M., Libermann T.A., Richon V.M., Marks P.A., and Anderson K.C. Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 540-545
32. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., and Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87 (1996) 953-959
33. Pan Y.X., Xu J., Mahurter L., Bolan E., Xu M., and Pasternak G.W. Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 14084-14089
34. Peart M.J., Smyth G.K., van Laar R.K., Bowtell D.D., Richon V.M., Marks P.A., Holloway A.J., and Johnstone R.W. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3697-3702
35. Reid G., Métivier R., Lin C.Y., Denger S., Ibberson D., Ivacevic T., Brand H., Benes V., Liu E.T., and Gannon F. Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A. Oncogene 24 (2005) 4894-4907
36. Riderle C., Christensen H., Schweiger S., Lehrach H., and Yaspo M. AIRE encodes a nuclear protein co-localizing with cytoskeletal filaments: altered sub-cellular distribution of mutants lacking the PHD zinc fingers. Hum. Mol. Genet. 8 (1998) 277-290
37. Rivera-Gines A., Cook R.J., Loh H.H., and Ko J.L. Interplay of Sps and Poly C binding protein 1 on the mu-opioid receptor gene expression. Biochem. Biophys. Res. Commun. 345 (2006) 530-537
38. Saha R.N., and Pahan K. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ. 13 (2006) 539-550
39. Schnur N., Seuter S., Katryniok C., Rådmark O., and Steinhilber D. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes. Biochim. Biophys. Acta 1771 (2007) 271-1282
40. Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J., Mizzen C.A., McKenna N.J., Onate S.A., Tsai S.Y., Tsai M.J., and O'Malley B.W. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389 (1997) 194-198
41. Sowa Y., Orita T., Minamikawa-Hiranabe S., Mizuno T., Nomura H., and Sakai T. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res. 59 (1999) 4266-4270
42. Van Lint C., Emiliani S., and Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 5 (1996) 245-253
43. Xiao H., Hasegawa T., and Isobe K. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. J. Cell. Biochem. 73 (1999) 291-302
44. Zhang Y., Liao M., and Dufau M.L. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression of transcription of the luteinizing hormone receptor gene. Mol. Cell. Biol. 26 (2006) 6748-6761